NYSTATIN

NYSTATIN was reported 27604 times

NYSTATIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SALPINGO-OOPHORECTOMY UNILATERAL 48 0.4364
1 TOTAL LUNG CAPACITY INCREASED 97 0.3566
2 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 97 0.1855
3 VENOUS PRESSURE JUGULAR INCREASED 30 0.0826
4 SINUSITIS FUNGAL 57 0.0711
5 TRICHOGLOSSIA 26 0.0634
6 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 54 0.0508
7 JAUNDICE CHOLESTATIC 175 0.0495
8 HYPOMANIA 182 0.0494
9 NEPHROGENIC ANAEMIA 199 0.0429
10 FEMALE GENITAL TRACT FISTULA 66 0.0386
11 HYPERPARATHYROIDISM SECONDARY 96 0.0383
12 ORAL CANDIDIASIS 458 0.0347
13 PELVIC MASS 28 0.0347
14 SEPSIS NEONATAL 26 0.0320
15 CANDIDA INFECTION 532 0.0315
16 NASAL POLYPS 152 0.0308
17 RHINITIS ALLERGIC 135 0.0303
18 SPUTUM INCREASED 65 0.0300
19 KYPHOSIS 52 0.0294
20 RECTAL PROLAPSE 34 0.0281
21 OROPHARYNGEAL CANDIDIASIS 25 0.0276
22 COMPLICATIONS OF TRANSPLANTED KIDNEY 61 0.0269
23 PARAINFLUENZAE VIRUS INFECTION 39 0.0256
24 SARCOIDOSIS 112 0.0236
25 CHRONIC SINUSITIS 88 0.0234
26 ORAL FUNGAL INFECTION 63 0.0230
27 CANDIDIASIS 92 0.0229
28 INFECTION REACTIVATION 26 0.0227
29 MUCORMYCOSIS 58 0.0223
30 PHARYNGEAL ULCERATION 29 0.0219
31 DIASTOLIC DYSFUNCTION 67 0.0217
32 RESPIRATORY SYMPTOM 61 0.0214
33 BK VIRUS INFECTION 71 0.0210
34 REBOUND ACID HYPERSECRETION 63 0.0208
35 TONGUE ULCERATION 70 0.0207
36 SCHIZOPHRENIA 250 0.0206
37 VULVOVAGINAL CANDIDIASIS 27 0.0200
38 CHRONIC RESPIRATORY FAILURE 24 0.0199
39 ESSENTIAL HYPERTENSION 34 0.0186
40 BRONCHIECTASIS 125 0.0185
41 LOBAR PNEUMONIA 34 0.0183
42 EMBOLISM VENOUS 53 0.0175
43 FAILURE TO THRIVE 87 0.0167
44 ENTEROBACTER INFECTION 28 0.0166
45 ODYNOPHAGIA 96 0.0161
46 TRANSPLANT REJECTION 128 0.0160
47 END STAGE RENAL DISEASE 291 0.0159
48 FUNGAL SKIN INFECTION 64 0.0158
49 CARDIAC MURMUR 137 0.0158
50 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 37 0.0158
51 KIDNEY TRANSPLANT REJECTION 74 0.0154
52 OESOPHAGEAL CANDIDIASIS 61 0.0153
53 TRICUSPID VALVE INCOMPETENCE 121 0.0152
54 KLEBSIELLA INFECTION 77 0.0152
55 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 24 0.0150
56 OSTEOLYSIS 30 0.0147
57 TONGUE COATED 25 0.0145
58 ENTEROCOCCAL INFECTION 68 0.0141
59 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 46 0.0139
60 OTITIS MEDIA 46 0.0139
61 DIVERTICULUM 98 0.0138
62 NOCARDIOSIS 34 0.0133
63 HIATUS HERNIA 168 0.0130
64 RENAL TUBULAR NECROSIS 125 0.0127
65 BLOOD CULTURE POSITIVE 38 0.0127
66 RHINOVIRUS INFECTION 49 0.0126
67 BUNDLE BRANCH BLOCK LEFT 53 0.0125
68 ATELECTASIS 120 0.0124
69 ESCHERICHIA BACTERAEMIA 29 0.0123
70 EXCORIATION 30 0.0118
71 CHRONIC KIDNEY DISEASE 894 0.0118
72 EXPOSED BONE IN JAW 25 0.0115
73 GRANULOMA 39 0.0113
74 PNEUMONIA FUNGAL 44 0.0111
75 ISCHAEMIC CARDIOMYOPATHY 34 0.0111
76 PSEUDOMONAS INFECTION 95 0.0111
77 IRON DEFICIENCY ANAEMIA 102 0.0110
78 ORTHOSTATIC HYPOTENSION 192 0.0110
79 AORTIC ARTERIOSCLEROSIS 28 0.0109
80 ASPERGILLUS INFECTION 71 0.0108
81 LUNG NEOPLASM 46 0.0108
82 HYDRONEPHROSIS 80 0.0107
83 OBSTRUCTIVE AIRWAYS DISORDER 118 0.0106
84 FEBRILE NEUTROPENIA 700 0.0105
85 CLOSTRIDIUM DIFFICILE COLITIS 110 0.0104
86 FUNGAL INFECTION 344 0.0103
87 STAPHYLOCOCCAL BACTERAEMIA 44 0.0101
88 ESCHERICHIA URINARY TRACT INFECTION 43 0.0101
89 BLOOD CHLORIDE DECREASED 26 0.0101
90 MUCOSAL INFLAMMATION 264 0.0101
91 LEFT VENTRICULAR HYPERTROPHY 43 0.0100
92 SERUM SICKNESS 28 0.0100
93 TOXIC EPIDERMAL NECROLYSIS 152 0.0100
94 ORAL DISORDER 72 0.0098
95 CHOLELITHIASIS 318 0.0097
96 NEUTROPENIC SEPSIS 69 0.0097
97 BLOOD BILIRUBIN INCREASED 259 0.0096
98 STAPHYLOCOCCAL SEPSIS 47 0.0095
99 ECONOMIC PROBLEM 144 0.0095
100 OESOPHAGEAL STENOSIS 27 0.0095
101 CAROTID ARTERY STENOSIS 33 0.0094
102 MOUTH ULCERATION 196 0.0093
103 SPINAL OSTEOARTHRITIS 81 0.0092
104 EMPHYSEMA 93 0.0092
105 PNEUMONIA VIRAL 29 0.0091
106 APLASTIC ANAEMIA 47 0.0090
107 LUNG INFILTRATION 79 0.0089
108 ACUTE RESPIRATORY FAILURE 171 0.0089
109 OESOPHAGITIS 97 0.0089
110 SLEEP APNOEA SYNDROME 169 0.0088
111 CYTOMEGALOVIRUS VIRAEMIA 39 0.0088
112 BLOOD ALBUMIN DECREASED 69 0.0087
113 ORAL PAIN 192 0.0086
114 HEPATOTOXICITY 188 0.0084
115 DECUBITUS ULCER 68 0.0083
116 INTERVERTEBRAL DISC DEGENERATION 77 0.0083
117 CYTOMEGALOVIRUS INFECTION 135 0.0081
118 HYPOVOLAEMIA 47 0.0080
119 UROSEPSIS 74 0.0080
120 TONGUE DISCOLOURATION 35 0.0080
121 VASCULAR DEVICE INFECTION 36 0.0079
122 BREATH SOUNDS ABNORMAL 39 0.0079
123 GLOSSITIS 28 0.0079
124 DIABETIC NEUROPATHY 39 0.0079
125 OESOPHAGEAL ULCER 30 0.0078
126 LYME DISEASE 26 0.0078
127 GINGIVITIS 42 0.0078
128 AZOTAEMIA 31 0.0078
129 SKIN INFECTION 87 0.0077
130 OLIGURIA 48 0.0077
131 ORAL INFECTION 30 0.0077
132 TRANSFUSION 80 0.0076
133 INFUSION SITE HAEMORRHAGE 25 0.0076
134 PEPTIC ULCER 25 0.0075
135 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 41 0.0075
136 PRE-EXISTING CONDITION IMPROVED 47 0.0075
137 UPPER-AIRWAY COUGH SYNDROME 62 0.0075
138 MITRAL VALVE INCOMPETENCE 85 0.0075
139 HYPERVOLAEMIA 37 0.0075
140 BONE LESION 27 0.0075
141 IMPAIRED GASTRIC EMPTYING 101 0.0074
142 HYSTERECTOMY 64 0.0074
143 CARDIOMEGALY 90 0.0073
144 PATENT DUCTUS ARTERIOSUS 29 0.0073
145 APHTHOUS ULCER 56 0.0072
146 CHEILITIS 39 0.0072
147 SKIN ABRASION 34 0.0072
148 PULMONARY CONGESTION 94 0.0071
149 ANHEDONIA 185 0.0070
150 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 365 0.0070
151 TUBULOINTERSTITIAL NEPHRITIS 130 0.0069
152 HERPES SIMPLEX 45 0.0069
153 BACTERAEMIA 81 0.0068
154 PSYCHOTIC DISORDER 200 0.0068
155 BUNDLE BRANCH BLOCK RIGHT 31 0.0067
156 URINE OUTPUT DECREASED 59 0.0067
157 ESCHERICHIA INFECTION 55 0.0067
158 TOOTH INFECTION 88 0.0067
159 GRAFT VERSUS HOST DISEASE 48 0.0067
160 INFUSION SITE SWELLING 42 0.0067
161 SPINAL COMPRESSION FRACTURE 55 0.0066
162 HYPERLIPIDAEMIA 79 0.0066
163 OSTEOPENIA 100 0.0066
164 CELLULITIS 331 0.0066
165 SEPSIS 732 0.0066
166 MENTAL STATUS CHANGES 180 0.0065
167 RENAL FAILURE 860 0.0065
168 ACUTE KIDNEY INJURY 979 0.0064
169 FLUID OVERLOAD 93 0.0064
170 RENAL FAILURE CHRONIC 49 0.0064
171 STOMATITIS 386 0.0064
172 MALNUTRITION 71 0.0063
173 RENAL CYST 50 0.0063
174 SEPTIC SHOCK 273 0.0063
175 SMALL INTESTINAL OBSTRUCTION 77 0.0062
176 HEPATIC LESION 27 0.0062
177 GASTROOESOPHAGEAL REFLUX DISEASE 500 0.0062
178 FLANK PAIN 58 0.0062
179 HYPOXIA 217 0.0062
180 RENAL INJURY 183 0.0062
181 DYSPNOEA EXERTIONAL 232 0.0062
182 VITAMIN D DEFICIENCY 60 0.0061
183 OSTEOPOROSIS 253 0.0061
184 WHEEZING 363 0.0061
185 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 31 0.0061
186 HYPERURICAEMIA 25 0.0061
187 HOSPICE CARE 60 0.0061
188 POSTOPERATIVE WOUND INFECTION 41 0.0061
189 HAEMATOCRIT DECREASED 120 0.0060
190 CACHEXIA 31 0.0060
191 PERIPHERAL VASCULAR DISORDER 31 0.0060
192 RED CELL DISTRIBUTION WIDTH INCREASED 25 0.0060
193 STEVENS-JOHNSON SYNDROME 133 0.0060
194 OSTEOARTHRITIS 253 0.0060
195 RENAL FAILURE ACUTE 253 0.0060
196 CYTOMEGALOVIRUS INFECTION REACTIVATION 26 0.0059
197 PHARYNGITIS 73 0.0059
198 MULTIPLE INJURIES 37 0.0059
199 PROTHROMBIN TIME PROLONGED 35 0.0058
200 HYPOVOLAEMIC SHOCK 28 0.0058
201 PRODUCTIVE COUGH 278 0.0058
202 PULMONARY HYPERTENSION 121 0.0058
203 RESPIRATORY SYNCYTIAL VIRUS INFECTION 50 0.0057
204 MULTIPLE ALLERGIES 45 0.0057
205 VAGINAL INFECTION 27 0.0057
206 DIVERTICULUM INTESTINAL 25 0.0057
207 BLOOD TEST ABNORMAL 80 0.0057
208 AORTIC VALVE INCOMPETENCE 24 0.0056
209 INFUSION SITE EXTRAVASATION 35 0.0056
210 HYPERKERATOSIS 31 0.0056
211 MULTIPLE MYELOMA 26 0.0056
212 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 28 0.0055
213 RALES 32 0.0055
214 PLEURAL EFFUSION 334 0.0055
215 DRUG LEVEL ABOVE THERAPEUTIC 25 0.0055
216 DENTAL CARIES 60 0.0054
217 SINUS TACHYCARDIA 77 0.0054
218 WOUND INFECTION 59 0.0054
219 RESPIRATORY FAILURE 392 0.0054
220 BLOOD UREA INCREASED 90 0.0054
221 LEFT VENTRICULAR DYSFUNCTION 36 0.0054
222 SEASONAL ALLERGY 76 0.0054
223 RESPIRATORY DISTRESS 148 0.0054
224 HAEMODIALYSIS 45 0.0054
225 LYMPHOEDEMA 37 0.0053
226 UPPER RESPIRATORY TRACT INFECTION 246 0.0053
227 SKIN ULCER 137 0.0053
228 URINARY TRACT INFECTION 902 0.0053
229 OEDEMA PERIPHERAL 644 0.0053
230 PANCYTOPENIA 295 0.0053
231 HYPOPHOSPHATAEMIA 39 0.0053
232 ABDOMINAL HERNIA 24 0.0053
233 TOOTH FRACTURE 58 0.0053
234 ELECTROLYTE IMBALANCE 61 0.0052
235 STAPHYLOCOCCAL INFECTION 173 0.0052
236 HYPOMAGNESAEMIA 73 0.0052
237 PNEUMONIA 1695 0.0052
238 COMPRESSION FRACTURE 28 0.0052
239 SUPRAVENTRICULAR TACHYCARDIA 50 0.0052
240 INFUSION SITE ERYTHEMA 44 0.0052
241 HYPERNATRAEMIA 26 0.0052
242 BLOOD MAGNESIUM DECREASED 45 0.0052
243 BLOOD POTASSIUM DECREASED 156 0.0052
244 HYPOGAMMAGLOBULINAEMIA 34 0.0052
245 COVID-19 PNEUMONIA 61 0.0052
246 SCOLIOSIS 32 0.0052
247 PATHOLOGICAL FRACTURE 26 0.0051
248 HAEMORRHOIDS 99 0.0051
249 CYSTIC FIBROSIS 28 0.0051
250 CYTOKINE RELEASE SYNDROME 101 0.0050
251 OSTEOMYELITIS 91 0.0050
252 PULMONARY OEDEMA 224 0.0050
253 ROTATOR CUFF SYNDROME 64 0.0050
254 TONSILLITIS 26 0.0050
255 ORAL DISCOMFORT 69 0.0050
256 LUNG INFECTION 77 0.0050
257 BRONCHOPULMONARY ASPERGILLOSIS 38 0.0049
258 PULMONARY MASS 73 0.0049
259 PLEURISY 29 0.0049
260 DYSPHAGIA 462 0.0049
261 GOUT 87 0.0048
262 INFLAMMATORY MARKER INCREASED 24 0.0048
263 ARTERIOSCLEROSIS CORONARY ARTERY 32 0.0048
264 ABSCESS 77 0.0048
265 NEPHROPATHY 45 0.0048
266 CARDIOGENIC SHOCK 69 0.0048
267 DEVICE RELATED INFECTION 74 0.0048
268 PNEUMONIA BACTERIAL 44 0.0048
269 PNEUMOTHORAX 76 0.0048
270 SINUSITIS 491 0.0048
271 PERIPHERAL SENSORY NEUROPATHY 28 0.0048
272 HYDROCEPHALUS 26 0.0048
273 HYPOKALAEMIA 220 0.0048
274 DERMATITIS ACNEIFORM 29 0.0048
275 PNEUMONITIS 129 0.0047
276 GASTROENTERITIS 69 0.0047
277 CARPAL TUNNEL SYNDROME 66 0.0047
278 TENDERNESS 49 0.0047
279 HYPOPHAGIA 120 0.0047
280 ENTEROCOLITIS 27 0.0047
281 GASTRITIS 123 0.0047
282 ILEUS 58 0.0047
283 INTRACRANIAL PRESSURE INCREASED 26 0.0047
284 CEREBRAL ISCHAEMIA 24 0.0047
285 MUSCULOSKELETAL CHEST PAIN 72 0.0046
286 PNEUMONIA ASPIRATION 116 0.0046
287 EPSTEIN-BARR VIRUS INFECTION 29 0.0046
288 DECREASED ACTIVITY 50 0.0046
289 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 36 0.0046
290 LEUKOPENIA 231 0.0046
291 GLOSSODYNIA 103 0.0046
292 PHARYNGEAL SWELLING 45 0.0046
293 GASTROENTERITIS VIRAL 83 0.0046
294 DEHYDRATION 613 0.0046
295 PNEUMOCYSTIS JIROVECII PNEUMONIA 46 0.0046
296 LYMPHADENOPATHY 162 0.0046
297 HAEMOLYTIC ANAEMIA 41 0.0046
298 SQUAMOUS CELL CARCINOMA 43 0.0046
299 BLOOD CREATININE INCREASED 298 0.0046
300 SHOCK HAEMORRHAGIC 37 0.0045
301 RESPIRATORY TRACT INFECTION 118 0.0045
302 ECCHYMOSIS 31 0.0045
303 OBESITY 72 0.0045
304 HYPOALBUMINAEMIA 35 0.0045
305 IMMUNODEFICIENCY 67 0.0045
306 EXOSTOSIS 41 0.0045
307 CLOSTRIDIUM DIFFICILE INFECTION 98 0.0045
308 TACHYPNOEA 61 0.0045
309 LEUKOCYTOSIS 81 0.0045
310 BLOOD ALKALINE PHOSPHATASE INCREASED 111 0.0045
311 BACTERIAL INFECTION 83 0.0044
312 SPUTUM DISCOLOURED 42 0.0044
313 RIB FRACTURE 91 0.0044
314 TONGUE DISORDER 32 0.0044
315 ENCEPHALOPATHY 108 0.0044
316 GINGIVAL PAIN 35 0.0044
317 NEUTROPHIL COUNT INCREASED 45 0.0044
318 DEEP VEIN THROMBOSIS 283 0.0044
319 PROCTALGIA 28 0.0044
320 DRUG LEVEL BELOW THERAPEUTIC 24 0.0043
321 BLOOD SODIUM DECREASED 82 0.0043
322 LIGAMENT SPRAIN 43 0.0043
323 PHARYNGITIS STREPTOCOCCAL 47 0.0043
324 IMMUNE SYSTEM DISORDER 57 0.0043
325 SECRETION DISCHARGE 54 0.0043
326 TOOTHACHE 78 0.0043
327 ATRIAL FIBRILLATION 416 0.0043
328 ORAL HERPES 83 0.0042
329 LARYNGEAL OEDEMA 26 0.0042
330 TROPONIN INCREASED 32 0.0042
331 ACIDOSIS 32 0.0042
332 PSYCHOLOGICAL TRAUMA 36 0.0042
333 BONE DISORDER 76 0.0042
334 HEPATIC ENZYME INCREASED 284 0.0042
335 INCONTINENCE 44 0.0042
336 SQUAMOUS CELL CARCINOMA OF SKIN 25 0.0041
337 THROMBOCYTOPENIA 462 0.0041
338 GENERALISED OEDEMA 51 0.0041
339 OXYGEN SATURATION DECREASED 231 0.0041
340 SALIVARY HYPERSECRETION 41 0.0041
341 RESPIRATORY TRACT CONGESTION 65 0.0041
342 HYPERKALAEMIA 143 0.0041
343 LYMPHOCYTE COUNT DECREASED 72 0.0041
344 SINUS CONGESTION 55 0.0041
345 BLOOD POTASSIUM INCREASED 66 0.0041
346 JOINT EFFUSION 28 0.0041
347 CARDIOMYOPATHY 60 0.0041
348 CARDIAC FAILURE CONGESTIVE 326 0.0041
349 EJECTION FRACTION DECREASED 63 0.0040
350 CYSTITIS 129 0.0040
351 UPPER GASTROINTESTINAL HAEMORRHAGE 68 0.0040
352 PYELONEPHRITIS 35 0.0040
353 FACIAL PAIN 36 0.0040
354 BLADDER DISORDER 40 0.0040
355 TOOTH ABSCESS 41 0.0040
356 PETECHIAE 42 0.0040
357 BREAST MASS 27 0.0040
358 OEDEMA 217 0.0040
359 ANAEMIA 759 0.0040
360 HYPONATRAEMIA 224 0.0040
361 VIRAL INFECTION 132 0.0040
362 COLITIS 150 0.0040
363 ADRENAL INSUFFICIENCY 48 0.0040
364 SKIN LACERATION 43 0.0040
365 RED BLOOD CELL COUNT DECREASED 113 0.0039
366 ELECTROCARDIOGRAM ABNORMAL 31 0.0039
367 TASTE DISORDER 80 0.0039
368 HAEMODYNAMIC INSTABILITY 30 0.0039
369 CONJUNCTIVITIS 73 0.0039
370 BRONCHITIS 291 0.0039
371 LOWER GASTROINTESTINAL HAEMORRHAGE 29 0.0039
372 APPETITE DISORDER 26 0.0039
373 URINARY INCONTINENCE 116 0.0039
374 OROPHARYNGEAL PAIN 362 0.0039
375 HAEMATOMA 101 0.0039
376 HAEMOGLOBIN ABNORMAL 25 0.0039
377 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 32 0.0039
378 INFUSION SITE PAIN 50 0.0039
379 ASCITES 114 0.0039
380 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 37 0.0039
381 RASH MACULO-PAPULAR 86 0.0039
382 EAR PAIN 75 0.0039
383 COLITIS ISCHAEMIC 26 0.0039
384 ASTHMA 435 0.0038
385 MAJOR DEPRESSION 28 0.0038
386 FOLLICULITIS 40 0.0038
387 INCREASED TENDENCY TO BRUISE 35 0.0038
388 QUALITY OF LIFE DECREASED 51 0.0038
389 FOOT FRACTURE 72 0.0038
390 EAR INFECTION 101 0.0038
391 INSURANCE ISSUE 58 0.0038
392 NEUTROPENIA 515 0.0038
393 FULL BLOOD COUNT ABNORMAL 40 0.0038
394 HYPERBILIRUBINAEMIA 39 0.0038
395 VENTRICULAR TACHYCARDIA 62 0.0038
396 ERYTHEMA MULTIFORME 35 0.0037
397 MYOCARDITIS 43 0.0037
398 DEFORMITY 35 0.0037
399 LETHARGY 215 0.0037
400 EMBOLISM 31 0.0037
401 MASS 52 0.0037
402 HAEMATEMESIS 94 0.0037
403 PULMONARY EMBOLISM 352 0.0037
404 LOWER RESPIRATORY TRACT INFECTION 168 0.0037
405 PAPULE 26 0.0037
406 DERMATITIS CONTACT 42 0.0037
407 SKIN LESION 101 0.0037
408 GASTROINTESTINAL INFECTION 33 0.0037
409 TENDONITIS 57 0.0037
410 BODY TEMPERATURE INCREASED 75 0.0037
411 BLOOD LACTATE DEHYDROGENASE INCREASED 58 0.0037
412 UNRESPONSIVE TO STIMULI 94 0.0036
413 RESPIRATION ABNORMAL 25 0.0036
414 DYSPHONIA 212 0.0036
415 NOCTURIA 44 0.0036
416 CONCUSSION 28 0.0036
417 LARGE INTESTINE POLYP 25 0.0036
418 HAEMATURIA 123 0.0036
419 HAEMOPTYSIS 100 0.0036
420 LIP SWELLING 119 0.0036
421 WHITE BLOOD CELL COUNT INCREASED 137 0.0036
422 PAIN IN JAW 101 0.0036
423 DRUG LEVEL INCREASED 59 0.0036
424 OSTEONECROSIS OF JAW 88 0.0036
425 IMPAIRED QUALITY OF LIFE 51 0.0035
426 GROIN PAIN 31 0.0035
427 PLATELET COUNT INCREASED 46 0.0035
428 COUGH 987 0.0035
429 ARTHROPOD BITE 26 0.0035
430 ARTERIOSCLEROSIS 33 0.0035
431 HYPERGLYCAEMIA 127 0.0035
432 MYOPATHY 30 0.0035
433 RETCHING 74 0.0035
434 FISTULA 39 0.0035
435 BLOOD CALCIUM DECREASED 39 0.0035
436 APNOEA 27 0.0035
437 RESTLESS LEGS SYNDROME 63 0.0035
438 ATRIAL SEPTAL DEFECT 29 0.0035
439 PERICARDIAL EFFUSION 80 0.0035
440 GASTROINTESTINAL PAIN 38 0.0035
441 ANAL INCONTINENCE 31 0.0034
442 FAECES SOFT 25 0.0034
443 HAEMOGLOBIN DECREASED 352 0.0034
444 GASTRIC ULCER 65 0.0034
445 LACERATION 32 0.0034
446 HAND FRACTURE 24 0.0034
447 BURSITIS 41 0.0034
448 ASPIRATION 37 0.0034
449 DIFFUSE LARGE B-CELL LYMPHOMA 26 0.0034
450 MULTI-ORGAN FAILURE 58 0.0034
451 NEUROPATHY PERIPHERAL 318 0.0033
452 FOOT DEFORMITY 37 0.0033
453 PYREXIA 1155 0.0033
454 SENSATION OF FOREIGN BODY 28 0.0033
455 OROPHARYNGEAL DISCOMFORT 30 0.0033
456 FAECES DISCOLOURED 72 0.0033
457 PRODUCT ADMINISTRATION INTERRUPTED 26 0.0033
458 INTERVERTEBRAL DISC PROTRUSION 72 0.0033
459 FURUNCLE 26 0.0033
460 EYE INFECTION 37 0.0033
461 CYTOPENIA 40 0.0033
462 LIVER FUNCTION TEST ABNORMAL 95 0.0033
463 MACULAR DEGENERATION 39 0.0033
464 POST PROCEDURAL HAEMORRHAGE 38 0.0033
465 INTERNATIONAL NORMALISED RATIO INCREASED 93 0.0033
466 DYSURIA 120 0.0033
467 ATRIAL FLUTTER 26 0.0033
468 FEEDING DISORDER 66 0.0033
469 BONE MARROW FAILURE 66 0.0032
470 INFECTION 469 0.0032
471 MICTURITION URGENCY 37 0.0032
472 CONSTIPATION 705 0.0032
473 ANKLE FRACTURE 50 0.0032
474 HEPATIC STEATOSIS 60 0.0032
475 HYPERCHOLESTEROLAEMIA 31 0.0032
476 KIDNEY INFECTION 63 0.0032
477 ALANINE AMINOTRANSFERASE INCREASED 197 0.0032
478 PROTEINURIA 61 0.0032
479 NEURALGIA 78 0.0032
480 SCIATICA 51 0.0032
481 BEDRIDDEN 42 0.0032
482 TOOTH DISORDER 71 0.0032
483 HERPES ZOSTER 183 0.0032
484 NASAL CONGESTION 187 0.0032
485 THROMBOTIC MICROANGIOPATHY 31 0.0032
486 HYPERCALCAEMIA 39 0.0032
487 ACUTE MYELOID LEUKAEMIA 49 0.0031
488 DIVERTICULITIS 87 0.0031
489 PRODUCT DISTRIBUTION ISSUE 29 0.0031
490 POST PROCEDURAL COMPLICATION 60 0.0031
491 HYPOCALCAEMIA 59 0.0031
492 PLATELET COUNT DECREASED 332 0.0031
493 SKIN HAEMORRHAGE 46 0.0031
494 DIALYSIS 44 0.0031
495 RHINITIS 25 0.0031
496 HYPOTHYROIDISM 99 0.0031
497 EATING DISORDER 66 0.0031
498 GASTROINTESTINAL HAEMORRHAGE 259 0.0031
499 LOCAL SWELLING 54 0.0031
500 GLOMERULAR FILTRATION RATE DECREASED 38 0.0031
501 RENAL IMPAIRMENT 259 0.0031
502 SINUS DISORDER 61 0.0031
503 SUBDURAL HAEMATOMA 44 0.0031
504 SWOLLEN TONGUE 96 0.0031
505 DRY MOUTH 249 0.0031
506 VAGINAL DISCHARGE 31 0.0031
507 THROAT IRRITATION 137 0.0031
508 HICCUPS 25 0.0030
509 RESPIRATORY DISORDER 91 0.0030
510 VOMITING 1428 0.0030
511 ASPARTATE AMINOTRANSFERASE INCREASED 161 0.0030
512 NEPHROLITHIASIS 139 0.0030
513 NEPHROPATHY TOXIC 34 0.0030
514 INTESTINAL PERFORATION 34 0.0030
515 METASTASES TO CENTRAL NERVOUS SYSTEM 39 0.0030
516 LOCALISED INFECTION 73 0.0030
517 IMPAIRED HEALING 99 0.0030
518 DECREASED APPETITE 700 0.0030
519 APHONIA 42 0.0030
520 BLISTER 169 0.0030
521 ELECTROCARDIOGRAM QT PROLONGED 108 0.0030
522 HEPATIC ENCEPHALOPATHY 28 0.0030
523 APPENDICITIS 28 0.0030
524 SPLENOMEGALY 35 0.0030
525 VENTRICULAR EXTRASYSTOLES 31 0.0030
526 IRRITABLE BOWEL SYNDROME 64 0.0030
527 RASH ERYTHEMATOUS 142 0.0030
528 LYMPHOPENIA 42 0.0030
529 HYPOTENSION 595 0.0030
530 ABDOMINAL PAIN 686 0.0029
531 ACUTE RESPIRATORY DISTRESS SYNDROME 52 0.0029
532 CHOLECYSTITIS 35 0.0029
533 GINGIVAL BLEEDING 40 0.0029
534 RESPIRATORY RATE INCREASED 26 0.0029
535 HIP FRACTURE 94 0.0029
536 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 30 0.0029
537 MUSCLE ATROPHY 37 0.0029
538 MUSCULOSKELETAL DISCOMFORT 50 0.0029
539 TOOTH EXTRACTION 36 0.0029
540 HEMIPARESIS 49 0.0029
541 DISEASE PROGRESSION 342 0.0029
542 MUSCLE STRAIN 25 0.0029
543 BLOOD TRIGLYCERIDES INCREASED 51 0.0029
544 DIARRHOEA 1861 0.0029
545 DELIRIUM 100 0.0029
546 URINARY RETENTION 96 0.0029
547 CORONARY ARTERY DISEASE 87 0.0029
548 LUNG NEOPLASM MALIGNANT 118 0.0029
549 MUSCULAR WEAKNESS 326 0.0029
550 PULMONARY FIBROSIS 55 0.0029
551 ATAXIA 34 0.0029
552 CONTUSION 275 0.0029
553 EPISTAXIS 213 0.0028
554 DIABETIC KETOACIDOSIS 68 0.0028
555 RECTAL HAEMORRHAGE 121 0.0028
556 SWELLING 261 0.0028
557 PARAESTHESIA ORAL 40 0.0028
558 FLUID RETENTION 141 0.0028
559 PLASMA CELL MYELOMA 108 0.0028
560 NIGHT SWEATS 89 0.0028
561 WEIGHT DECREASED 771 0.0028
562 FIBROMYALGIA 67 0.0028
563 DRY THROAT 28 0.0028
564 DYSPEPSIA 271 0.0028
565 CHROMATURIA 62 0.0027
566 SPINAL DISORDER 26 0.0027
567 DYSPNOEA 1550 0.0027
568 FULL BLOOD COUNT DECREASED 55 0.0027
569 MYOCARDIAL ISCHAEMIA 31 0.0027
570 IMMUNOSUPPRESSION 24 0.0027
571 INFLAMMATION 140 0.0027
572 NERVE COMPRESSION 25 0.0027
573 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 130 0.0027
574 ANXIETY 768 0.0027
575 BRAIN OEDEMA 34 0.0027
576 PULMONARY ARTERIAL HYPERTENSION 39 0.0027
577 HYPERTENSION 569 0.0027
578 HYPERSOMNIA 77 0.0027
579 WOUND 75 0.0027
580 CARDIAC ARREST 221 0.0027
581 JOINT STIFFNESS 70 0.0027
582 TACHYCARDIA 237 0.0027
583 BLOOD PRESSURE SYSTOLIC INCREASED 52 0.0027
584 BACK PAIN 619 0.0027
585 VASCULITIS 31 0.0027
586 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 62 0.0027
587 THYROID DISORDER 41 0.0027
588 CYST 33 0.0027
589 ABDOMINAL DISTENSION 277 0.0027
590 NAUSEA 2099 0.0026
591 LIMB INJURY 72 0.0026
592 ULCER 42 0.0026
593 NEUTROPHIL COUNT DECREASED 107 0.0026
594 DIABETES MELLITUS 199 0.0026
595 NERVE INJURY 29 0.0026
596 NODULE 34 0.0026
597 MUSCLE SPASTICITY 32 0.0026
598 MYOCLONUS 31 0.0026
599 METASTASES TO LUNG 30 0.0026
600 BRONCHOSPASM 37 0.0026
601 HEPATIC FAILURE 78 0.0026
602 TYPE 2 DIABETES MELLITUS 87 0.0026
603 BLOOD PRESSURE FLUCTUATION 62 0.0026
604 DERMATITIS 54 0.0026
605 ASTHENIA 968 0.0026
606 THROMBOSIS 207 0.0026
607 HAIR COLOUR CHANGES 32 0.0026
608 CHEST DISCOMFORT 262 0.0026
609 PERIPHERAL SWELLING 394 0.0026
610 JOINT DISLOCATION 27 0.0026
611 POLLAKIURIA 106 0.0025
612 NECK PAIN 142 0.0025
613 FALL 844 0.0025
614 HEAD INJURY 80 0.0025
615 GALLBLADDER DISORDER 45 0.0025
616 SPINAL OPERATION 31 0.0025
617 WHITE BLOOD CELL COUNT DECREASED 272 0.0025
618 INJURY 176 0.0025
619 METABOLIC ACIDOSIS 80 0.0025
620 HEPATITIS 64 0.0025
621 SKIN DISORDER 83 0.0025
622 CATARACT 148 0.0025
623 WEIGHT FLUCTUATION 26 0.0025
624 CYANOSIS 39 0.0025
625 LIVER FUNCTION TEST INCREASED 53 0.0025
626 CHOKING 48 0.0025
627 NO THERAPEUTIC RESPONSE 30 0.0025
628 SUBARACHNOID HAEMORRHAGE 25 0.0025
629 APHASIA 74 0.0024
630 CHILLS 287 0.0024
631 LOWER LIMB FRACTURE 47 0.0024
632 SPINAL FRACTURE 49 0.0024
633 HEPATOMEGALY 24 0.0024
634 BODY TEMPERATURE DECREASED 24 0.0024
635 MULTIPLE FRACTURES 40 0.0024
636 DISABILITY 48 0.0024
637 CONFUSIONAL STATE 392 0.0024
638 CHEST PAIN 449 0.0024
639 CONDITION AGGRAVATED 736 0.0024
640 WRIST FRACTURE 29 0.0024
641 DYSARTHRIA 91 0.0024
642 SKIN REACTION 34 0.0024
643 RHINORRHOEA 156 0.0024
644 FATIGUE 1877 0.0024
645 COAGULOPATHY 40 0.0024
646 HEPATIC CIRRHOSIS 45 0.0024
647 JOINT INJURY 51 0.0024
648 MUSCULOSKELETAL PAIN 125 0.0024
649 HEART RATE INCREASED 236 0.0024
650 METASTASES TO BONE 39 0.0024
651 MUSCLE SPASMS 436 0.0024
652 ARTHRITIS 186 0.0024
653 TOOTH LOSS 49 0.0024
654 DISEASE RECURRENCE 112 0.0024
655 PALLOR 64 0.0023
656 DRUG TOXICITY 32 0.0023
657 BREAST PAIN 25 0.0023
658 VENTRICULAR FIBRILLATION 26 0.0023
659 HAEMORRHAGE INTRACRANIAL 35 0.0023
660 GAIT DISTURBANCE 447 0.0023
661 METASTASES TO LIVER 41 0.0023
662 EMOTIONAL DISTRESS 281 0.0023
663 DEPRESSION 525 0.0023
664 DERMATITIS ALLERGIC 29 0.0023
665 RASH 1003 0.0023
666 BIPOLAR DISORDER 25 0.0023
667 BLOOD PRESSURE INCREASED 351 0.0023
668 PANCREATITIS 121 0.0023
669 DRUG INTERACTION 363 0.0023
670 SCAB 26 0.0023
671 SYNCOPE 228 0.0023
672 BALANCE DISORDER 196 0.0023
673 LUNG DISORDER 111 0.0023
674 DYSGEUSIA 168 0.0023
675 THROAT TIGHTNESS 61 0.0023
676 INTESTINAL OBSTRUCTION 85 0.0023
677 ECZEMA 118 0.0023
678 C-REACTIVE PROTEIN INCREASED 82 0.0023
679 PAIN IN EXTREMITY 664 0.0023
680 EYE PAIN 127 0.0022
681 ANOREXIA 29 0.0022
682 INSOMNIA 596 0.0022
683 JOINT RANGE OF MOTION DECREASED 30 0.0022
684 RASH MACULAR 78 0.0022
685 DYSSTASIA 65 0.0022
686 TRANSIENT ISCHAEMIC ATTACK 75 0.0022
687 PRESYNCOPE 54 0.0022
688 DRUG RESISTANCE 57 0.0022
689 INFLUENZA 247 0.0022
690 ILLNESS 228 0.0022
691 BLOOD URINE PRESENT 42 0.0022
692 RENAL DISORDER 103 0.0022
693 BACK INJURY 24 0.0022
694 INFUSION RELATED REACTION 146 0.0022
695 DISSEMINATED INTRAVASCULAR COAGULATION 31 0.0022
696 SKIN FISSURES 43 0.0022
697 SWELLING FACE 143 0.0022
698 HALLUCINATION 165 0.0022
699 PHOTOPHOBIA 41 0.0022
700 COVID-19 381 0.0022
701 TREMOR 360 0.0022
702 MALIGNANT NEOPLASM PROGRESSION 222 0.0022
703 SKIN EXFOLIATION 182 0.0022
704 THERAPY NON-RESPONDER 96 0.0021
705 FLATULENCE 121 0.0021
706 SPINAL PAIN 25 0.0021
707 DRY EYE 106 0.0021
708 HYPOAESTHESIA ORAL 32 0.0021
709 CIRCULATORY COLLAPSE 36 0.0021
710 JOINT SWELLING 255 0.0021
711 BLOOD COUNT ABNORMAL 32 0.0021
712 BONE DENSITY DECREASED 66 0.0021
713 COLITIS ULCERATIVE 94 0.0021
714 PAIN 1291 0.0021
715 INTERNAL HAEMORRHAGE 24 0.0021
716 WEIGHT INCREASED 469 0.0021
717 HAIR TEXTURE ABNORMAL 28 0.0021
718 MELAENA 46 0.0021
719 HYPOAESTHESIA 312 0.0021
720 NASOPHARYNGITIS 384 0.0021
721 BURNING SENSATION 146 0.0021
722 HEART RATE IRREGULAR 47 0.0021
723 ACTIVITIES OF DAILY LIVING IMPAIRED 41 0.0021
724 LYMPHOMA 32 0.0021
725 PSORIATIC ARTHROPATHY 84 0.0021
726 INTENTIONAL DOSE OMISSION 59 0.0021
727 HYPOKINESIA 30 0.0021
728 BONE LOSS 31 0.0021
729 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 35 0.0021
730 SEIZURE 238 0.0021
731 SLEEP DISORDER 145 0.0021
732 BASAL CELL CARCINOMA 32 0.0020
733 DEPRESSED LEVEL OF CONSCIOUSNESS 81 0.0020
734 RASH GENERALISED 53 0.0020
735 AGEUSIA 51 0.0020
736 POOR QUALITY SLEEP 44 0.0020
737 COLD SWEAT 36 0.0020
738 BRAIN FOG 32 0.0020
739 NEOPLASM PROGRESSION 71 0.0020
740 ARTHRALGIA 847 0.0020
741 GAMMA-GLUTAMYLTRANSFERASE INCREASED 45 0.0020
742 BACK DISORDER 33 0.0020
743 TRANSAMINASES INCREASED 45 0.0020
744 GASTROINTESTINAL DISORDER 181 0.0020
745 PROCEDURAL PAIN 56 0.0020
746 BLOOD CHOLESTEROL INCREASED 94 0.0020
747 PHARYNGEAL OEDEMA 31 0.0020
748 THIRST 36 0.0020
749 MIGRAINE 192 0.0020
750 NEUROTOXICITY 35 0.0020
751 SYNOVITIS 36 0.0020
752 SCAR 34 0.0020
753 BONE PAIN 116 0.0020
754 SKIN DISCOLOURATION 91 0.0020
755 DIABETES MELLITUS INADEQUATE CONTROL 35 0.0020
756 INTENTIONAL PRODUCT USE ISSUE 173 0.0020
757 DYSKINESIA 80 0.0020
758 LABORATORY TEST ABNORMAL 58 0.0020
759 FREQUENT BOWEL MOVEMENTS 53 0.0020
760 MOBILITY DECREASED 140 0.0019
761 GAIT INABILITY 65 0.0019
762 LIMB DISCOMFORT 60 0.0019
763 ABDOMINAL PAIN LOWER 49 0.0019
764 RASH PRURITIC 105 0.0019
765 COORDINATION ABNORMAL 27 0.0019
766 GLAUCOMA 37 0.0019
767 LACRIMATION INCREASED 58 0.0019
768 ANGINA PECTORIS 55 0.0019
769 PARANOIA 33 0.0019
770 SHOCK 44 0.0019
771 FRACTURE 36 0.0019
772 BLOOD PRESSURE DECREASED 126 0.0019
773 NERVOUS SYSTEM DISORDER 59 0.0019
774 MALAISE 827 0.0019
775 COGNITIVE DISORDER 88 0.0019
776 HAEMATOCHEZIA 104 0.0019
777 GENERAL PHYSICAL HEALTH DETERIORATION 218 0.0019
778 HEART RATE DECREASED 66 0.0019
779 TARDIVE DYSKINESIA 53 0.0019
780 MIDDLE INSOMNIA 35 0.0019
781 GENERALISED TONIC-CLONIC SEIZURE 31 0.0019
782 PRODUCT DOSE OMISSION IN ERROR 53 0.0019
783 BRADYCARDIA 99 0.0019
784 HYPERTHYROIDISM 27 0.0019
785 VISION BLURRED 256 0.0019
786 MOOD SWINGS 59 0.0018
787 DEVICE OCCLUSION 26 0.0018
788 HALLUCINATION, VISUAL 39 0.0018
789 HYPERSENSITIVITY 342 0.0018
790 ABDOMINAL PAIN UPPER 377 0.0018
791 FEAR 49 0.0018
792 ARRHYTHMIA 86 0.0018
793 HYPOGLYCAEMIA 88 0.0018
794 BLOOD PRESSURE ABNORMAL 36 0.0018
795 TREATMENT NONCOMPLIANCE 99 0.0018
796 UPPER LIMB FRACTURE 36 0.0018
797 MULTIPLE ORGAN DYSFUNCTION SYNDROME 51 0.0018
798 AGITATION 132 0.0018
799 ABDOMINAL DISCOMFORT 301 0.0018
800 HOT FLUSH 135 0.0018
801 PRODUCT USE IN UNAPPROVED INDICATION 443 0.0018
802 ERYTHEMA 365 0.0018
803 SPEECH DISORDER 93 0.0018
804 MUSCULOSKELETAL STIFFNESS 155 0.0018
805 MEMORY IMPAIRMENT 243 0.0018
806 OSTEONECROSIS 58 0.0018
807 DEAFNESS 46 0.0018
808 PARAESTHESIA 276 0.0018
809 PRURITUS 669 0.0017
810 PERITONITIS 36 0.0017
811 ACUTE MYOCARDIAL INFARCTION 51 0.0017
812 OFF LABEL USE 1510 0.0017
813 DISCOMFORT 105 0.0017
814 FACE OEDEMA 29 0.0017
815 EMOTIONAL DISORDER 53 0.0017
816 SEDATION 45 0.0017
817 HOSPITALISATION 264 0.0017
818 THINKING ABNORMAL 32 0.0017
819 HEADACHE 1076 0.0017
820 ALOPECIA 336 0.0017
821 DRUG INTOLERANCE 165 0.0017
822 MYALGIA 290 0.0017
823 SYSTEMIC LUPUS ERYTHEMATOSUS 60 0.0017
824 DIZZINESS 839 0.0017
825 CARDIAC FAILURE 135 0.0017
826 COLON CANCER 25 0.0017
827 ANGIOEDEMA 74 0.0017
828 ANAPHYLACTIC REACTION 92 0.0017
829 MYELODYSPLASTIC SYNDROME 24 0.0017
830 PALPITATIONS 194 0.0017
831 RASH PAPULAR 37 0.0016
832 SNEEZING 37 0.0016
833 ROAD TRAFFIC ACCIDENT 69 0.0016
834 PANCREATITIS ACUTE 37 0.0016
835 SURGERY 96 0.0016
836 APPLICATION SITE PAIN 36 0.0016
837 THERAPEUTIC RESPONSE UNEXPECTED 73 0.0016
838 SOMNOLENCE 327 0.0016
839 DISORIENTATION 64 0.0016
840 HAEMORRHAGE 168 0.0016
841 PRESCRIBED UNDERDOSE 32 0.0016
842 FEELING COLD 44 0.0016
843 DRUG ERUPTION 28 0.0016
844 INFLUENZA LIKE ILLNESS 130 0.0016
845 CARDIO-RESPIRATORY ARREST 66 0.0016
846 HIP ARTHROPLASTY 24 0.0016
847 ILL-DEFINED DISORDER 95 0.0016
848 IRRITABILITY 94 0.0016
849 LOSS OF CONSCIOUSNESS 200 0.0016
850 RESTLESSNESS 57 0.0016
851 HERNIA 30 0.0015
852 ARTHROPATHY 86 0.0015
853 MUSCLE TIGHTNESS 25 0.0015
854 CONVULSION 88 0.0015
855 DEMENTIA 43 0.0015
856 AMNESIA 100 0.0015
857 SKIN CANCER 33 0.0015
858 FEELING HOT 93 0.0015
859 UNEVALUABLE EVENT 114 0.0015
860 PRODUCT DOSE OMISSION ISSUE 438 0.0015
861 JAUNDICE 40 0.0015
862 FEMUR FRACTURE 46 0.0015
863 THERAPY INTERRUPTED 106 0.0015
864 HYPERHIDROSIS 191 0.0015
865 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 25 0.0015
866 ABASIA 36 0.0015
867 URTICARIA 244 0.0015
868 EYE SWELLING 54 0.0015
869 THERAPEUTIC RESPONSE DECREASED 88 0.0014
870 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 103 0.0014
871 CEREBROVASCULAR ACCIDENT 245 0.0014
872 BLOOD GLUCOSE INCREASED 272 0.0014
873 PSORIASIS 188 0.0014
874 DRY SKIN 192 0.0014
875 DEATH 1236 0.0014
876 EYE DISORDER 47 0.0014
877 PRODUCT USE ISSUE 266 0.0014
878 RESPIRATORY ARREST 39 0.0014
879 HEAD DISCOMFORT 25 0.0014
880 SEROTONIN SYNDROME 27 0.0014
881 AGRANULOCYTOSIS 26 0.0014
882 VERTIGO 85 0.0014
883 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 251 0.0014
884 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 76 0.0014
885 DEPRESSED MOOD 73 0.0014
886 EOSINOPHILIA 24 0.0014
887 FEELING ABNORMAL 328 0.0014
888 PRODUCT DOSE OMISSION 89 0.0014
889 INTERSTITIAL LUNG DISEASE 66 0.0014
890 CHOLESTASIS 26 0.0014
891 GASTRIC DISORDER 46 0.0013
892 CARDIAC DISORDER 125 0.0013
893 ANGER 45 0.0013
894 LIVER DISORDER 59 0.0013
895 CEREBRAL INFARCTION 32 0.0013
896 DIPLOPIA 34 0.0013
897 TINNITUS 60 0.0013
898 ERUCTATION 25 0.0013
899 BLOOD GLUCOSE DECREASED 62 0.0013
900 DYSTONIA 25 0.0013
901 MENTAL DISORDER 56 0.0013
902 OCULAR HYPERAEMIA 61 0.0013
903 MOVEMENT DISORDER 41 0.0013
904 ADVERSE DRUG REACTION 112 0.0012
905 NERVOUSNESS 65 0.0012
906 KNEE ARTHROPLASTY 26 0.0012
907 PANIC ATTACK 45 0.0012
908 NEOPLASM MALIGNANT 82 0.0012
909 GLYCOSYLATED HAEMOGLOBIN INCREASED 31 0.0012
910 MUSCLE TWITCHING 28 0.0012
911 FLUSHING 123 0.0012
912 MYOCARDIAL INFARCTION 209 0.0012
913 EYE PRURITUS 40 0.0012
914 THERAPY CESSATION 61 0.0012
915 ABNORMAL BEHAVIOUR 47 0.0012
916 PRODUCT AVAILABILITY ISSUE 27 0.0012
917 VISUAL IMPAIRMENT 146 0.0012
918 ACCIDENTAL OVERDOSE 43 0.0012
919 MENTAL IMPAIRMENT 28 0.0012
920 BLOOD CREATINE PHOSPHOKINASE INCREASED 33 0.0011
921 EYE IRRITATION 65 0.0011
922 CEREBRAL HAEMORRHAGE 40 0.0011
923 DRUG-INDUCED LIVER INJURY 35 0.0011
924 HYPOACUSIS 48 0.0011
925 PAIN OF SKIN 30 0.0011
926 LACTIC ACIDOSIS 36 0.0011
927 MULTIPLE SCLEROSIS 53 0.0011
928 ALTERED STATE OF CONSCIOUSNESS 24 0.0011
929 EXTRAPYRAMIDAL DISORDER 26 0.0010
930 CRYING 38 0.0010
931 MEDICATION ERROR 58 0.0010
932 MOOD ALTERED 28 0.0010
933 LIVER INJURY 25 0.0010
934 INJECTION SITE RASH 31 0.0010
935 DRUG INEFFECTIVE 1318 0.0010
936 VISUAL ACUITY REDUCED 33 0.0010
937 VAGINAL HAEMORRHAGE 43 0.0010
938 RHABDOMYOLYSIS 41 0.0010
939 BLINDNESS 40 0.0010
940 RHEUMATOID ARTHRITIS 109 0.0010
941 THERAPEUTIC RESPONSE SHORTENED 31 0.0009
942 SUICIDAL IDEATION 85 0.0009
943 CONTRAINDICATED PRODUCT ADMINISTERED 28 0.0009
944 DRUG EFFECT INCOMPLETE 33 0.0009
945 DRUG DOSE OMISSION 148 0.0009
946 MULTIPLE SCLEROSIS RELAPSE 61 0.0009
947 ADVERSE EVENT 81 0.0009
948 DISTURBANCE IN ATTENTION 47 0.0009
949 INJECTION SITE BRUISING 69 0.0009
950 TREATMENT FAILURE 71 0.0009
951 DRUG ADMINISTRATION ERROR 26 0.0008
952 NIGHTMARE 29 0.0008
953 WITHDRAWAL SYNDROME 35 0.0008
954 TOXICITY TO VARIOUS AGENTS 140 0.0008
955 INTENTIONAL PRODUCT MISUSE 72 0.0008
956 THERAPEUTIC PRODUCT EFFECT DECREASED 36 0.0008
957 HEPATIC FUNCTION ABNORMAL 29 0.0008
958 COMA 37 0.0008
959 INJECTION SITE REACTION 52 0.0008
960 UNDERDOSE 54 0.0007
961 DRUG EXPOSURE DURING PREGNANCY 25 0.0007
962 AGGRESSION 36 0.0007
963 DEVICE DISLOCATION 31 0.0007
964 DRUG EFFECT DECREASED 38 0.0007
965 PRODUCT QUALITY ISSUE 92 0.0007
966 FOETAL EXPOSURE DURING PREGNANCY 53 0.0007
967 INJECTION SITE MASS 24 0.0006
968 ACNE 49 0.0006
969 DERMATITIS ATOPIC 34 0.0006
970 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 129 0.0006
971 INJECTION SITE PRURITUS 42 0.0006
972 INCORRECT DOSE ADMINISTERED 142 0.0006
973 EXPOSURE DURING PREGNANCY 38 0.0006
974 SKIN IRRITATION 28 0.0006
975 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 43 0.0006
976 INJECTION SITE SWELLING 46 0.0006
977 INJECTION SITE PAIN 174 0.0006
978 INJECTION SITE ERYTHEMA 69 0.0006
979 DEVICE ISSUE 46 0.0005
980 DEVICE MALFUNCTION 36 0.0005
981 OVERDOSE 108 0.0005
982 SKIN BURNING SENSATION 34 0.0005
983 SUICIDE ATTEMPT 26 0.0004
984 NO ADVERSE EVENT 74 0.0004
985 INJECTION SITE HAEMORRHAGE 30 0.0004
986 PROSTATE CANCER 29 0.0004
987 DRUG WITHDRAWAL SYNDROME 31 0.0004
988 MATERNAL EXPOSURE DURING PREGNANCY 28 0.0003
989 PRODUCT STORAGE ERROR 26 0.0003
990 ACCIDENTAL EXPOSURE TO PRODUCT 30 0.0003
991 BREAST CANCER 24 0.0003
992 DRUG DEPENDENCE 38 0.0002